04 Jun 2012, BioSpectrum Bureau , BioSpectrum
Singapore: Pomerantz Haudek Grossman & Gross LLP is investigating claims on behalf of investors of Tibet Pharmaceuticals. It has been alleged that the specialty pharmaceutical company made materially false and misleading statements and omissions regarding the firm's financial performance and future prospects.
Tibet Pharmaceuticals focuses on the R&D, manufacturing and marketing of modernized traditional Tibetan medicines. The Pomerantz Firm, which was founded 75 years ago, has offices in New York and Chicago. It is recognized as one of the premier firms in the areas of corporate, securities, and antitrust class litigation.